As VRC Director, Dr. Mascola provides scientific leadership to the basic, clinical, and translational research activities of the VRC;
develops vaccine research programs to meet public health needs; allocates VRC resources; and develops policies for the execution of multi-disciplinary research.
Not exact matches
The call to execute certain drug traffickers is drawing the most attention, but another part of the plan could make a big difference: The White House will support
research into
developing a
vaccine for opioid addiction.
«If they could figure out a way to streamline, it would be a lot better,» said Kim Janda, a professor of chemistry at the Scripps
Research Institute in La Jolla, California, who leads a team of researchers
developing a
vaccine that would prevent fentanyl overdoses by keeping the drug from reaching the brain.
National and local health care officials said cuts in federal spending to combat the Zika virus means fewer pregnant women will be tested and there will be less money available to
develop a
vaccine and
research how the disease affects fetal brains.
Today, we have
developed some kits and
vaccines for the disease through our
research unit.
The National Institute on Drug Abuse is pursuing a mix of approaches that include
developing non-opioid pain medicines, conducting
research on
vaccines that may blunt the impact of fentanyl and its related offshoots, getting public health organizations to increase the availability and use of medications already available to treat opioid addiction and getting medications such as buprenorphine and naloxone, which suppress withdrawal symptoms and ease cravings, into the hands emergency room doctors dealing with patients with opioid addictions.
The
research in the treatment of the disease has gone very well, but what the less -
developed world needs, and what we need, too, is a
vaccine.
Developing a
vaccine against HIV is still our best hope for containing the AIDS pandemic, says Danilo Casimiro, Merck's director of basic
vaccine research.
The guideline recommendations were
developed by a multinational and multidisciplinary panel of oncology, obstetrics / gynecology, public health, cancer control, epidemiology / biostatistics, health economics, behavioral / implementation science, and patient advocacy experts, including some of the world's foremost
research leaders on HPV and HPV
vaccines.
The agency has ongoing
research examining the effectiveness of drugs such as methadone, buprenorphine, and naltrexone that are used to wean people off of stronger opioids, as well as
research developing alternatives such as
vaccines and transcranial magnetic stimulation to treat opioid addictions.
Koff says the next milestone will be later stage clinical testing of a
vaccine developed by the federally funded National Institutes of Health Vaccine Research Center, which should begin nex
vaccine developed by the federally funded National Institutes of Health
Vaccine Research Center, which should begin nex
Vaccine Research Center, which should begin next year.
Advances in biotechnology are giving
vaccine research a shot in the arm, increasing the opportunities to
develop new
vaccines — and careers.
Now a
research team, led by investigators at the Duke Human Vaccine Institute and the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), has tracked rare potent antibodies in an HIV - infected individual and determined sequential structures that point to how they de
research team, led by investigators at the Duke Human
Vaccine Institute and the
Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), has tracked rare potent antibodies in an HIV - infected individual and determined sequential structures that point to how they de
Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), has tracked rare potent antibodies in an HIV - infected individual and determined sequential structures that point to how they
developed.
Scientists contacted by Nature say that basic
research on such mutated strains may eventually yield insight relevant to
developing pandemic countermeasures such as drugs and
vaccines.
New
research, led by University of Southampton biological scientist Dr Hannah Siddle, is aiming to
develop an effective
vaccine against an infectious cancer that is eradicating the Tasmanian devil, the world's largest remaining marsupial carnivore.
His laboratory
research has focused on
developing a
vaccine that targets the bacterium Staphylococcus aureus and the fungus Candida; the
vaccine is undergoing clinical development.
We are hopeful that this
research takes us one step closer to
developing an AIDS
vaccine.»
A
research team at the Montreal Children's Hospital from the Research Institute of the McGill University Health Centre (RI - MUHC) is bringing them hope with a potential vaccine that nudges the immune response away from developing al
research team at the Montreal Children's Hospital from the
Research Institute of the McGill University Health Centre (RI - MUHC) is bringing them hope with a potential vaccine that nudges the immune response away from developing al
Research Institute of the McGill University Health Centre (RI - MUHC) is bringing them hope with a potential
vaccine that nudges the immune response away from
developing allergies.
A
research team at The University of Texas at El Paso is one step closer to
developing an effective human
vaccine for cutaneous leishmaniasis, a tropical disease found in Texas and Oklahoma, and affecting some U.S. troops stationed in Afghanistan and Iraq.
Now scientists at The Scripps
Research Institute (TSRI) have
developed a method to analyze the glycan shield on HIV's protective outer glycoprotein,
developed as a potential HIV
vaccine candidate.
Meanwhile,
research continues at St. Jude and elsewhere to
develop more effective flu
vaccines, particularly for high - risk groups, including the elderly, pregnant women and obese individuals.
«This
research team's dedication and previous
research on dengue and other arboviruses enabled them to quickly
develop this model for Zika virus, an important first step to enable testing of candidate
vaccine and therapeutics,» said Stephen Higgs, PhD, the president of the American Society of Tropical Medicine and Hygiene.
Because this
research does not require replicating «live» viruses, it does not need to be done in high - level containment facilities when
developing vaccines for highly pathogenic viruses.
Kang's primary
research focuses on designing and
developing effective
vaccines against viral diseases such as influenza virus and RSV, but he partnered with a university and
research institutes in South Korea that wanted international collaborative projects to study if ginseng can be used to improve health and protect against disease because of the potential benefit in fighting these viruses.
Recent
research has yielded new information about immune responses associated with — and potentially responsible for — protection from HIV infection, providing leads for new strategies to
develop an HIV
vaccine.
Scientists at The Scripps
Research Institute (TSRI) have made a discovery that could speed efforts to
develop a successful HIV
vaccine.
In response to the threat, scientists at the U.S. Army Medical
Research Institute of Infectious Diseases have
developed a new recombinant protein
vaccine.
«Our lab has been
developing a
vaccine for years now based on our
research of this disease,» said Bicalho.
In an effort to provide broad protection against meningitis, the researchers are now
developing a
vaccine that would prevent the bacteria from recognizing the laminin receptor, according to Elaine Tuomanen, a leader of the study and a physician at St. Jude Children's
Research Hospital in Memphis, Tennessee.
Despite the accelerated pace of
research, much remains unknown about the virus, raising unique challenges in
developing a
vaccine.
The
research and public - health networks established during the SARS epidemic — and the body of coronavirus
research that followed — puts scientists today in a much stronger position to understand the latest virus and to
develop countermeasures such as drugs and
vaccines, should they be required.
HeLa cell - based
research has been instrumental in
developing vaccines and fighting AIDS and cancer, but it has not been without controversy.
At a 10 June press conference, Children's Hospital Oakland
Research Institute (CHORI), which was developing an anthrax vaccine for children, announced that six people involved with the research are now taking ciprofloxacin, an ant
Research Institute (CHORI), which was
developing an anthrax
vaccine for children, announced that six people involved with the
research are now taking ciprofloxacin, an ant
research are now taking ciprofloxacin, an antibiotic.
Developing - country
research is producing world - class results: a meningitis
vaccine in Cuba, malaria treatment in Thailand, a $ 300 basic computer in Brazil.
The researchers theorize that vaccinating camels could reduce the risk of MERS - CoV transmission to people and other camels; NIAID and others are supporting
research to
develop candidate
vaccines for potential use in people and camels.
The NIH's
Vaccine Research Center (VRC) has developed a similar vaccine that is in earlier - stage t
Vaccine Research Center (VRC) has
developed a similar
vaccine that is in earlier - stage t
vaccine that is in earlier - stage testing.
The work and other similar, recent studies could also help «redefine» how
vaccines are
developed to make them more effective and less likely to have side effects, says Wayne Koff, the chief scientific officer at the International AIDS
Vaccine Initiative in New York City, who was not involved with the
research.
It is critical to continue and accelerate a robust
research effort to
develop an HIV
vaccine that is at least moderately effective, while also aggressively scaling up the implementation of current treatment and prevention tools, Dr. Fauci concludes.
Public health policy and
research must overcome several barriers to
developing vaccines for pregnant women, say authors Saad B. Omer, MBBS, PhD, professor of global health, epidemiology and pediatrics at Emory University and Richard H. Beigi, MD, MSc, associate professor of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh Medical Center and chief medical officer at Magee - Womens Hospital of UPMC.
Loans will also be used to help countries stockpile antiviral drugs, enhance animal and human health surveillance systems,
develop preparedness plans, and support
vaccine research.
A novel
vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, protected cattle from respiratory syncytial virus (RSV) infection, according to
research published online in npj
Vaccines on March 8.
So for several decades,
research focused on
developing a
vaccine for each of the four serotypes and then combining them.
At present the MRC's AIDS
research is divided into two arms: the strategic programme, which covers work on the nature of AIDS and its treatment, and monitors the spread of HIV; and the directed programme, which is targeted specifically at
developing drugs and
vaccines.
Efforts to
develop a universal flu
vaccine may have stalled, but the
research has revealed an antibody that protects against several lethal flu strains
«Uncovering the process by which neutralizing antibodies
develop is critical to HIV
vaccine design,» said Elise Landais, Senior
Research Scientist with IAVI and lead author of the study.
A
research team that includes scientists with Kansas State University's Biosecurity Research Institute has developed a promising Zika virus
research team that includes scientists with Kansas State University's Biosecurity
Research Institute has developed a promising Zika virus
Research Institute has
developed a promising Zika virus
vaccine.
This new discovery, funded by multiple groups, opens up novel possibilities for future
research aimed at
developing vaccines against these viruses to prevent type 1 diabetes.
«This
vaccine is a successful advancement in
developing control strategies for Zika virus by creating widespread immunity in susceptible populations,» said Stephen Higgs, director of the Biosecurity
Research Institute.
Cornell and Ludwig Institute for Cancer
Research scientists have developed a way to produce a protein antigen that may be useful as vaccine for schistosomiasis — a parasitic disease that infects millions of people, mostly in tropical and subtropical climates — according to new research in the journal Protein Expression and Purification, Ju
Research scientists have
developed a way to produce a protein antigen that may be useful as
vaccine for schistosomiasis — a parasitic disease that infects millions of people, mostly in tropical and subtropical climates — according to new
research in the journal Protein Expression and Purification, Ju
research in the journal Protein Expression and Purification, June 2017.
Yesterday, the country's government submitted a formal
vaccine trial protocol,
developed with Epicentre, the Paris - based
research arm of Doctors Without Borders (MSF), to an ethical review board.